Changes

no edit summary
Line 71: Line 71:  
| Anaplastic PXA, WHO grade III / Ganglioglioma, WHO Grade III
 
| Anaplastic PXA, WHO grade III / Ganglioglioma, WHO Grade III
 
| '''Loss:''' monosomy 9 / 9p deletion, but no diagnostic findings
 
| '''Loss:''' monosomy 9 / 9p deletion, but no diagnostic findings
| '''Mutation:'''  BRAF V600E less common here than in PXA, grade II  
+
| '''Mutation:'''  BRAF V600E less common here than in PXA, grade II<br>
 
'''Loss:''' CDKN2A/CDKN2B
 
'''Loss:''' CDKN2A/CDKN2B
 
| CDKN2A/CDKN2B loss may correlate with anaplastic histology
 
| CDKN2A/CDKN2B loss may correlate with anaplastic histology
Line 79: Line 79:  
|Glioblastoma, WHO grade IV
 
|Glioblastoma, WHO grade IV
 
|IDH-mutant  
 
|IDH-mutant  
|'''Gain:''' 1q, 2q, 3q, 7, 16p, 17q, 21q  
+
|'''Gain:''' 1q, 2q, 3q, 7, 16p, 17q, 21q<br>
 
'''Loss:''' 6q, 8q, 9p, 9q, 10q, 13q, 17p, 22q
 
'''Loss:''' 6q, 8q, 9p, 9q, 10q, 13q, 17p, 22q
 
''' Chromothripsis:''' observed
 
''' Chromothripsis:''' observed